Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on JAYWING PLC. We currently have 2 research reports from 2 professional analysts.
|06Dec16 10:05||RNS||Issue of Equity & PDMR Dealings|
|22Nov16 07:00||RNS||Half-year Report|
|30Sep16 15:22||RNS||Grant of Options|
|13Sep16 17:59||RNS||Holding(s) in Company|
|05Sep16 11:59||RNS||Holding(s) in Company|
|01Sep16 07:00||RNS||Acquisition & Placing to raise £3 million|
|25Aug16 12:00||RNS||Result of AGM|
Frequency of research reports
Research reports on
Data Driven Marketing
29 Feb 16
Jaywing is a UK marketing services company with a clearly differentiated market position in data science. Core, is the delivery of behavioural insights and algorithms to enhance the roi of clients marketing and customer experience programmes and, in a highly personalised way. The acquisition of search marketing specialist Epiphany in March 2014 was strategically transformative, giving Jaywing a profitable growth platform as well as consolidating its leading position in digital data and online media expertise. As the largest agency in the North of England, the company employs 600 people in the UK.
N+1 Singer - Morning Song 22-03-2017
22 Mar 17
Carador Income Fund (CIFU LN) Premium rating restored, high levels of refinancing activity | Cello Group (CLL LN) Outlook getting brighter – watch Pulsar | Eckoh (ECK LN) Largest ever US secure payments win | eg solutions (EGS LN) Full year results in line | Futura Medical (FUM LN) Licensing deal for CSD500 in Portugal | Verona Pharma (VRP LN) Global agreement with QuintilesIMS to support development of RPL554 | Xaar (XAR LN) 2016 results slightly ahead, reduced visibility in 2017
Small Cap Breakfast
21 Mar 17
First Sentinel—Investment company expecting NEX admission/introduction on 24 March. £636k raised pre-IPO. BioPharma Credit—Expected Gross Initial Acquisition Proceeds now c.$338m. Gross Cash Proceeds capped at $423m with placing and open offer. Results expected 23 March with admission now due 30 march. Tufton Oceanic Assets- The Company intends to invest in a diversified portfolio of second hand commercial sea-going vessels where the Investment Manager believes that an attractive opportunity exists in shipping. $150m raise. Admission 3 April.
Small Cap Breakfast
23 Mar 17
K3 Capital Group—Schedule 1 from the Group of business and company sales specialists across business transfer, business brokerage and corporate finance. Admission date and fundraise details TBC. Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April. Sentinel—Investment company expecting NEX admission/introduction on 24 March. £636k raised pre-IPO. BioPharma Credit—Expected Gross Initial Acquisition Proceeds now c.$338m. Gross Cash Proceeds capped at $423m with placing and open offer. Results expected 23 March with admission now due 30 march.
21 Mar 17
NAHL has a track record of being highly innovative around changes in regulation and we believe the changing personal injury landscape presents an opportunity to build market share. The recent strategy statement provides forecast benchmarks to base long term investment decisions. Whilst the shares are up 21% over the last month, valuations remain very modest with a FY17 PE of just 6.5x and a dividend yield of 10.4%. We believe the shares are meaningfully oversold and expect a recovery bounce to over 200p short term.
23 Mar 17
Once again, management has demonstrated its ability to deliver consistent growth. Our two-year forecast profile implies a further 20% growth in profitability accompanied by strong cash generation. However, the stock continues to sit at a significant discount to its peers, which on a current year EV/EBITDA basis is now 38%. We raise our target price to 66p following the introduction of a 2018 forecast, implying 57% upside, which would effectively halve the peer group discount.